| Literature DB >> 30021351 |
Xue-Mei Jiang1, Xiang-Nan Yu2, Tao-Tao Liu2, Hai-Rong Zhu2, Xuan Shi2, Enkhnaran Bilegsaikhan2, Hong-Ying Guo2, Guang-Qi Song2, Shu-Qiang Weng2, Xiao-Xi Huang3, Ling Dong2, Harry L A Janssen4, Xi-Zhong Shen5, Ji-Min Zhu6.
Abstract
microRNA-19a-3p (miR-19a-3p) has been reported to regulate cell proliferation in hepatocellular carcinoma (HCC), but its role in HCC metastasis remains unknown. In this study, miR-19a-3p was noted to be upregulated in HCC specimens and cell lines. Aberrant expression of miR-19a-3p stimulated HCC cell metastasis, and phosphatase and tensin homolog (PTEN) was shown to be a direct target of miR-19a-3p. miR-19a-3p-mediated HCC metastasis was reversed by restoration of PTEN or could be imitated by silencing of PTEN. Modulation of miR-19a-3p also altered expression of phosphorylated Akt, a downstream mediator of PTEN. Moreover, aberrant expression of miR-19a-3p induced sorafenib resistance by regulating the PTEN/Akt pathway. In conclusion, ectopic expression of miR-19a-3p contributes to HCC metastasis and chemoresistance by modulating PTEN expression and the PTEN-dependent pathways.Entities:
Keywords: Chemoresistance; Hepatocellular carcinoma; Metastasis; microRNA-19a-3p
Mesh:
Substances:
Year: 2018 PMID: 30021351 DOI: 10.1016/j.biopha.2018.06.097
Source DB: PubMed Journal: Biomed Pharmacother ISSN: 0753-3322 Impact factor: 6.529